ORIC Pharmaceuticals Inc
ORIC·Stocks·Pharmaceuticals Major·United States·Nasdaq·USD
Price
$12.97
Today
-2.7%
YTD
+60.6%
About
ORIC Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that develops and discovers therapeutic solutions to overcome resistance in cancer. Operating within the US, the company was founded in 2014 and has its headquarters in South San Francisco, California. Stock for ORIC Pharmaceuticals is listed on the NASDAQ GS using the ticker ORIC. Receive the most recent ORIC stock news by adding this instrument to your eToro watchlist.
Price chart
Closing price history for ORIC (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-7.58
P/S (TTM)0.00
P/B (TTM)2.70
Market cap$1.12B
Cap tierSmall-cap
Industry avg P/E-43.36
Profitability
Gross marginUnknown
EBIT margin0.00%
Net marginUnknown
ROE-42.57%
ROA-39.79%
Earnings & Revenue
Revenue (TTM)$0.00
Revenue growth (1Y)Unknown
EPS (TTM)-$1.43
Free cash flow$-114.35M
Total debt$3.30M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.43
Employees104
Next earnings12 Nov '26
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.